Congenica is a global digital health company enabling the rapid analysis and interpretation of genomic data, improving well-being and disease management and empowering health professionals to provide life-changing answers for patients and their families. Congenica’s software enables genomic data analysis at scale, performing analysis more than 20-times faster, reducing genomic interpretation costs by up to 95% and enabling higher diagnostic yields than previously possible – making precise personalized healthcare a reality. Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica has a global footprint supporting diagnostic laboratories, academic medical centres and biopharmaceutical companies.
